AYTU BIOPHARMA, INC Annual Income Tax Expense (Benefit) in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Aytu Biopharma, Inc annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2014 to 2024.
  • Aytu Biopharma, Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $245K.
  • Aytu Biopharma, Inc annual Income Tax Expense (Benefit) for 2024 was $1.77M.
  • Aytu Biopharma, Inc annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Aytu Biopharma, Inc annual Income Tax Expense (Benefit) for 2022 was -$110K, a 142% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.77M +$1.77M Jul 1, 2023 Jun 30, 2024 10-K 2024-09-26
2023 $0 +$110K Jul 1, 2022 Jun 30, 2023 10-K 2024-09-26
2022 -$110K -$369K -142% Jul 1, 2021 Jun 30, 2022 10-K 2023-10-12
2021 $259K +$259K Jul 1, 2020 Jun 30, 2021 10-K 2022-09-27
2020 $0 $0 Jul 1, 2019 Jun 30, 2020 10-K 2021-09-28
2019 $0 $0 Jul 1, 2018 Jun 30, 2019 10-K 2020-10-06
2018 $0 $0 Jul 1, 2017 Jun 30, 2018 10-K 2019-09-26
2017 $0 $0 Jul 1, 2016 Jun 30, 2017 10-K 2017-08-31
2016 $0 +$23.9K Jul 1, 2015 Jun 30, 2016 10-K 2017-08-31
2015 -$23.9K +$790K +97.1% Jul 1, 2014 Jun 30, 2015 10-K 2016-09-01
2014 -$814K Jul 1, 2013 Jun 30, 2014 10-K 2015-09-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.